何先弟, 李峰, 吴强. 重症监护病房160株革兰阴性杆菌耐药性监测[J]. 蚌埠医科大学学报, 2004, 29(6): 493-494.
    引用本文: 何先弟, 李峰, 吴强. 重症监护病房160株革兰阴性杆菌耐药性监测[J]. 蚌埠医科大学学报, 2004, 29(6): 493-494.
    He Xian-di, Li Feng, Wu Qiang. Survey of Gram-negative bacili resistance in Intensive Care Unit[J]. Journal of Bengbu Medical University, 2004, 29(6): 493-494.
    Citation: He Xian-di, Li Feng, Wu Qiang. Survey of Gram-negative bacili resistance in Intensive Care Unit[J]. Journal of Bengbu Medical University, 2004, 29(6): 493-494.

    重症监护病房160株革兰阴性杆菌耐药性监测

    Survey of Gram-negative bacili resistance in Intensive Care Unit

    • 摘要: 目的: 监测重症监护治疗病房患者中分离的革兰阴性杆菌耐药状况,探讨对耐药菌感染的治疗策略。方法: 用E试验测定160株革兰阴性杆菌对10种抗菌药物的最低抑菌浓度。结果: 亚胺培南对所有受试菌仍保持最高抗菌活性,细菌的耐药率为11.3%。产超广谱β内酰胺酶(ESBLs)菌41株,抗菌活性最强的是亚胺培南、头孢吡肟和舒巴坦-头孢哌酮,敏感率分别为88.7%、81.2%和79.4%。结论: 亚胺培南可作为ESBLs产生菌所致重症感染的首选药物,而头孢吡肟和β内酰胺酶抑制剂与β内酰胺酶类抗生素的复合剂可用来治疗产ESBLs菌株感染的选用药物之一。

       

      Abstract: Objective: To observe the Gram-negative bacterial resistance in patients in Intensive Care Unit(ICU) and to discuss how to treat infections caused by these resistant strains.Methods: The minimal inhibitory concentrations of 10 antibiotics against 160 strains of Gram-negative bacilli isolated from ICU patients were determined by E test.Results: The resistance rates to imipenem,cefepime and sulbactam-cefoperazone were the lowest,being 11.3%、18.8% and 20.6%,respectively.Forty-one ESBLs-producing strains were susceptible to imipenem,cefepime and sulbactam-cefoperazone,with a susceptible rate of 90.2%,82.9% and 80.5%,respectively.Conclusions: Imipenem is the most active agent against severe systemic infections caused by ESBLs-producing strains,while β-lactam/β-lactamase inhibitors are also active against most strains.

       

    /

    返回文章
    返回